USP

USP
Share

USP

 •  December 7, 2017

Fellows Will Examine the Link Between Substandard and Falsified Medicines and Antimicrobial Resistance FOR IMMEDIATE RELEASE CONTACT: Rockville, MD – December 6, 2017 – The USP Quality Institute and Georgetown University Medical Center announce the inaugural fellows selected for the institutions’ Fellowship in Quality Medical Products. The fellows...

USP

 •  November 29, 2017

Today, the World Health Organization released two authoritative reports illustrating the prevalence and impact of poor-quality medicines. According to the reports, one in ten medical products in low- and middle-income countries are either substandard or falsified. A statement follows from Ronald T. Piervincenzi, CEO, USP: “We applaud WHO and Dr....

USP

 •  November 22, 2017

In conversations about the role of quality standards in public health, you might come across the words “compendia” and “compendial.” At USP, terms like “compendial approaches,” “compendial standards,” and “compendial tools” are part of our everyday vocabulary. But their meaning can be a bit of a mystery to people who work outside of the...

USP

 •  September 26, 2017

Amid the backdrop of the 72nd United Nations General Assembly (UNGA), USP introduced its Quality Institute – a center that will conduct much-needed research to foster evidence-based policy decisions that can help increase the availability of quality-assured medicines worldwide. In my conversations with different stakeholders, I have seen that...

USP

 •  September 18, 2017

Ho Chi Minh City, formerly known as Saigon, is Vietnam’s most populous city and lies amid a confluence of rivers. For centuries, people have lived and traded along the rivers, with the mighty Mekong winding its way through Yunnan China, Lao PDR, Myanmar, Thailand, and Cambodia, before opening into the South China Sea at the mouth of Vietnam’s...

USP

 •  August 1, 2017

FOR IMMEDIATE RELEASE USP’s public standards are recognized in US Law, enforceable by the FDA and used in nearly 140 countries to ensure supply chain integrity, medicine and supplement quality Rockville, Md., November 17, 2015 — In response to a multi-agency sweep of dietary supplements that are unsafe, tainted and/or make unsubstantiated claims,...

USP

 •  August 1, 2017

Changes to Established System Could Cause Unintended Consequences Rockville, Md., November 17, 2015 — The United States Pharmacopeial Convention (USP) has submitted comments on the Food and Drug Administration’s (FDA) Proposed Rule, “Designation of Official Names and Proper Names for Certain Biological Products” (Proposed Rule). At the heart of...

USP

 •  June 26, 2017

Regardless of whether it’s prescription or over-the-counter, the ingredients on a drug product label typically include one, maybe two, active pharmaceutical ingredients (APIs). The rest of the list is comprised of “inactive” ingredients (excipients) which in reality are far from inactive. Their functions range from helping to guarantee the...

USP

 •  June 7, 2017

In late May, 2017, hundreds of public health experts converged in Geneva, Switzerland as the 70th World Health Assembly (WHA70) convened. On the agenda, the election of a new Director-General who would guide the World Health Organization (WHO) for the next five years, the implementation of WHO’s new Framework of Engagement with Non-State actors...

USP

 •  May 15, 2017

Every glass and elastomeric material used in pharmaceutical packaging or delivery systems should be safe and suitable for its intended use. Establishing the suitability of packaging systems for pharmaceutical products involves multiple tests and testing procedures, for which USP has established a number of minimum requirements. However, with many...